After a series of ups and downs in its proposed capital raise, Pine Island finalized its prospectus for a $200M IPO. Read more.
Related Posts
Inflection Point Acquisition II Files for $200M IPO
Inflection II plans to focus initially on North American and European businesses in disruptive growth sectors, which complements the expertise of the management team.
CM Life Sciences III Prices Upsized $480M IPO
The SPAC is led by by CEO Eli Casdin, founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry.
Eyeglasses Retailer Warby Parker Sets Direct Listing Date
The company plans to offer 77.74 million shares.
Trailblazer Merger I Prices $60M IPO on Nasdaq
The SPAC’s focus is on US companies within the tech industry. Trailblazer initially registered in July to raise $67.5 million, downsizing the offering in January before today's float.